Posted On: 12/17/2014 5:54:16 PM
Post# of 30066
Here's some examples of where the company said "will"
Sept. 10, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic interventions for Alzheimer's disease, Parkinson's disease and orphan ophthalmological disorders, today announced that Dr. Roman Urfer, Chief Development Officer at NeuroAssets Sarl, will be presenting efficacy data for MANF in an undisclosed orphan ocular indication at Targeting Ocular Disorders 2014.
http://ir.amarantus.com/company-news/detail/1...rence-2014
Nov. 17, 2014 - Amarantus' management team will host a conference call and webcast on November 18, 2014 at 8:00 a.m. EST to provide a business update.
http://ir.amarantus.com/company-news/detail/1...er-18-2014
Nov. 24, 2014 - Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a diversified biotechnology company focused on the development of diagnostic and therapeutic products in the areas of neurology, psychiatry, ophthalmology and regenerative medicine announced today that Gerald E. Commissiong, President and Chief Executive Officer, will present at the LD Micro Main Event VII micro-cap investor conference being held December 2 - 4, 2014 at the Luxe Sunset Hotel in Los Angeles, California.
http://ir.amarantus.com/company-news/detail/1...ber-2-2014
Sept. 10, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic interventions for Alzheimer's disease, Parkinson's disease and orphan ophthalmological disorders, today announced that Dr. Roman Urfer, Chief Development Officer at NeuroAssets Sarl, will be presenting efficacy data for MANF in an undisclosed orphan ocular indication at Targeting Ocular Disorders 2014.
http://ir.amarantus.com/company-news/detail/1...rence-2014
Nov. 17, 2014 - Amarantus' management team will host a conference call and webcast on November 18, 2014 at 8:00 a.m. EST to provide a business update.
http://ir.amarantus.com/company-news/detail/1...er-18-2014
Nov. 24, 2014 - Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a diversified biotechnology company focused on the development of diagnostic and therapeutic products in the areas of neurology, psychiatry, ophthalmology and regenerative medicine announced today that Gerald E. Commissiong, President and Chief Executive Officer, will present at the LD Micro Main Event VII micro-cap investor conference being held December 2 - 4, 2014 at the Luxe Sunset Hotel in Los Angeles, California.
http://ir.amarantus.com/company-news/detail/1...ber-2-2014
(0)
(0)
